🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/12/2018 | 107,71 | 108,85 | 105,15 | 106,10 | -0,46% | 3,44% | 211.500 |
| 17/12/2018 | 107,78 | 109,63 | 106,14 | 106,59 | -1,20% | 3,24% | 397.900 |
| 14/12/2018 | 109,20 | 110,97 | 107,51 | 107,89 | -2,05% | 3,17% | 399.000 |
| 13/12/2018 | 111,95 | 112,46 | 109,42 | 110,15 | -1,66% | 2,72% | 331.700 |
| 12/12/2018 | 111,52 | 113,95 | 110,91 | 112,01 | +2,02% | 2,73% | 385.800 |
| 11/12/2018 | 110,30 | 111,91 | 108,28 | 109,79 | +1,19% | 3,29% | 497.700 |
| 10/12/2018 | 109,45 | 110,20 | 106,73 | 108,50 | -0,86% | 3,17% | 351.300 |
| 07/12/2018 | 112,75 | 113,46 | 108,48 | 109,44 | -2,95% | 4,42% | 522.400 |
| 06/12/2018 | 111,58 | 113,93 | 110,61 | 112,77 | -0,46% | 2,98% | 474.600 |
| 04/12/2018 | 120,49 | 121,00 | 113,04 | 113,29 | -5,22% | 6,61% | 443.000 |
| 03/12/2018 | 118,06 | 119,76 | 116,83 | 119,53 | +1,21% | 2,48% | 514.600 |
| 30/11/2018 | 117,70 | 119,72 | 116,27 | 118,10 | +0,69% | 2,93% | 422.800 |
| 29/11/2018 | 116,93 | 118,70 | 116,69 | 117,29 | -0,38% | 1,72% | 254.700 |
| 28/11/2018 | 113,75 | 117,78 | 112,34 | 117,74 | +3,71% | 4,78% | 234.700 |
| 27/11/2018 | 114,15 | 114,48 | 112,74 | 113,53 | -1,37% | 1,52% | 262.100 |
| 26/11/2018 | 116,66 | 116,80 | 113,44 | 115,11 | -0,05% | 2,88% | 530.700 |
| 23/11/2018 | 113,74 | 116,66 | 111,65 | 115,17 | +0,83% | 4,40% | 200.600 |
| 21/11/2018 | 113,49 | 116,34 | 112,25 | 114,22 | +0,88% | 3,60% | 399.900 |
| 20/11/2018 | 115,04 | 116,60 | 112,66 | 113,22 | -2,83% | 3,42% | 327.800 |
| 19/11/2018 | 121,49 | 122,37 | 115,77 | 116,52 | -4,09% | 5,43% | 480.500 |
| 16/11/2018 | 115,98 | 122,14 | 114,41 | 121,49 | +4,45% | 6,66% | 400.400 |
| 15/11/2018 | 111,04 | 120,94 | 110,50 | 116,31 | +4,81% | 9,40% | 595.600 |
| 14/11/2018 | 113,39 | 114,16 | 109,16 | 110,97 | -1,55% | 4,41% | 377.500 |
| 13/11/2018 | 112,78 | 114,39 | 112,03 | 112,72 | +0,83% | 2,09% | 250.800 |
| 12/11/2018 | 114,30 | 115,16 | 111,51 | 111,79 | -2,27% | 3,19% | 312.300 |
| 09/11/2018 | 116,52 | 117,14 | 113,86 | 114,39 | -2,20% | 2,81% | 411.400 |
| 08/11/2018 | 116,98 | 119,39 | 116,15 | 116,96 | +0,35% | 2,77% | 338.800 |
| 07/11/2018 | 117,85 | 119,94 | 115,28 | 116,55 | -0,37% | 3,95% | 502.300 |
| 06/11/2018 | 115,24 | 118,06 | 115,24 | 116,98 | +1,67% | 2,45% | 398.200 |
| 05/11/2018 | 115,27 | 116,71 | 113,86 | 115,06 | +0,37% | 2,47% | 485.400 |